All Volunteers Inoculated with COVID-19 Vaccine by Vektor Center in Good Health

06 August 2020

GMP News

All volunteers inoculated with the vaccine against the coronavirus developed by the Vektor State Research Center of Virology and Biotechnology are in good health, no side effects of the vaccination are observed, the press service of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing told TASS on August 4.

“All vaccinated volunteers are in good health. No complications after the inoculation with the EpiVacCorona vaccine against the coronavirus have been recorded,” the statement said.

To date, three volunteers out of five have already been inoculated. The fourth one will be vaccinated on August 5. The sanitary watchdog noted that the volunteers remain under constant medical observation while no situations requiring medical aid arose.

“Double vaccination after 21 days is planned. The vaccine should facilitate the development of the immunity against the novel coronavirus infection after double administration with a 21-day interval. The data collection on the antibody levels will begin already after the first inoculation,” the press service explained.

Source

Print

Shareholders

Read more

Pipeline

Read more

Media Center

Read more